TGA considers two-packs of triptans for downscheduling

Pharmacists would need to assess the patient’s symptoms before dispensing

This story has been updated, see footnote.


The TGA is considering a proposal to schedule certain doses of triptans pharmacist-only for the treatment of acute migraine.

It is looking at proposals to move sumatriptan in 50mg tablets and zolmitriptan in 2.5mg tablets from schedule 4 to schedule 3 (appendix M) as part of the latest round of re-scheduling applications.

Both would be limited to packs of two tablets.

Appendix M allows the TGA impose certain conditions on pharmacists, such as using a patient checklist.

However, for